Olanzapine: The game-changer “antiemetic”
Chemotherapy-induced nausea and vomiting (CINV) is significantly debilitating and worsens the quality of life. Olanzapine, an atypical antipsychotic drug, also has an antiemetic potential. Studies have shown that olanzapine-based regimens have similar efficacy as compared to aprepitant in patients r...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2019-01-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=2;spage=274;epage=276;aulast=Dhanushkodi |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850259387608727552 |
|---|---|
| author | Manikandan Dhanushkodi |
| author_facet | Manikandan Dhanushkodi |
| author_sort | Manikandan Dhanushkodi |
| collection | DOAJ |
| description | Chemotherapy-induced nausea and vomiting (CINV) is significantly debilitating and worsens the quality of life. Olanzapine, an atypical antipsychotic drug, also has an antiemetic potential. Studies have shown that olanzapine-based regimens have similar efficacy as compared to aprepitant in patients receiving highly emetogenic chemotherapy (HEC). National Comprehensive Cancer Network guidelines also recommends olanzapine-based regimen in HEC. Olanzapine, palonosetron, dexamethasone regimen is a cost-effective option in resource-limited settings in patients receiving HEC. |
| format | Article |
| id | doaj-art-e1fe69a4a3d24e46a5e1cf70c2aee3f4 |
| institution | OA Journals |
| issn | 0971-5851 0975-2129 |
| language | English |
| publishDate | 2019-01-01 |
| publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
| record_format | Article |
| series | Indian Journal of Medical and Paediatric Oncology |
| spelling | doaj-art-e1fe69a4a3d24e46a5e1cf70c2aee3f42025-08-20T01:55:52ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58510975-21292019-01-0140227427610.4103/ijmpo.ijmpo_151_19Olanzapine: The game-changer “antiemetic”Manikandan DhanushkodiChemotherapy-induced nausea and vomiting (CINV) is significantly debilitating and worsens the quality of life. Olanzapine, an atypical antipsychotic drug, also has an antiemetic potential. Studies have shown that olanzapine-based regimens have similar efficacy as compared to aprepitant in patients receiving highly emetogenic chemotherapy (HEC). National Comprehensive Cancer Network guidelines also recommends olanzapine-based regimen in HEC. Olanzapine, palonosetron, dexamethasone regimen is a cost-effective option in resource-limited settings in patients receiving HEC.http://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=2;spage=274;epage=276;aulast=Dhanushkodichemotherapy-induced nausea and vomitinghighly emetogenic chemotherapyolanzapine |
| spellingShingle | Manikandan Dhanushkodi Olanzapine: The game-changer “antiemetic” Indian Journal of Medical and Paediatric Oncology chemotherapy-induced nausea and vomiting highly emetogenic chemotherapy olanzapine |
| title | Olanzapine: The game-changer “antiemetic” |
| title_full | Olanzapine: The game-changer “antiemetic” |
| title_fullStr | Olanzapine: The game-changer “antiemetic” |
| title_full_unstemmed | Olanzapine: The game-changer “antiemetic” |
| title_short | Olanzapine: The game-changer “antiemetic” |
| title_sort | olanzapine the game changer antiemetic |
| topic | chemotherapy-induced nausea and vomiting highly emetogenic chemotherapy olanzapine |
| url | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=2;spage=274;epage=276;aulast=Dhanushkodi |
| work_keys_str_mv | AT manikandandhanushkodi olanzapinethegamechangerantiemetic |